Turbinate Submucosal Reduction Operation Reduced Migraine Admission among Patients with Chronic Hypertrophic Rhinitis
Abstract
:1. Introduction
2. Materials and Methods
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Acknowledgments
Conflicts of Interest
References
- Wang, S.J.; Fuh, J.L.; Juang, K.D.; Lu, S.R. Rising prevalence of migraine in Taiwanese adolescents aged 13–15 years. Cephalalgia 2005, 25, 433–438. [Google Scholar] [CrossRef]
- Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 2013, 33, 629–808. [Google Scholar] [CrossRef] [Green Version]
- Doretti, A.; Shestaritc, I.; Ungaro, D.; Lee, J.I.; Lymperopoulos, L.; Kokoti, L.; Guglielmetti, M.; Mitsikostas, D.D.; Lampl, C. School of Advanced Studies of the European Headache Federation (EHF-SAS). Headaches in the emergency department–A survey of patients’ characteristics, facts and needs. J. Headache Pain 2019, 20, 100. [Google Scholar] [CrossRef] [Green Version]
- Diener, H.C.; Solbach, K.; Holle, D.; Gaul, C. Integrated care for chronic migraine patients: Epidemiology, burden, diagnosis and treatment options. Clin. Med. 2015, 15, 344–350. [Google Scholar] [CrossRef]
- Derebery, J.; Meltzer, E.; Nathan, R.A.; Stang, P.E.; Campbell, U.B.; Corrao, M.; Stanford, R. Rhinitis symptoms and comorbidities in the United States: Burden of rhinitis in America survey. Otolaryngol. Head Neck Surg. 2008, 139, 198–205. [Google Scholar] [CrossRef]
- Martin, V.T.; Fanning, K.M.; Serrano, D.; Buse, D.C.; Reed, M.L.; Bernstein, J.A.; Lipton, R.B. Chronic rhinitis and its association with headache frequency and disability in persons with migraine: Results of the American Migraine Prevalence and Prevention (AMPP) Study. Cephalalgia 2014, 34, 336–348. [Google Scholar] [CrossRef]
- Rains, J.C.; Poceta, J.S. Sleep-related headaches. Neurol. Clin. 2012, 30, 1285–1298. [Google Scholar] [CrossRef]
- Martin, V.T.; Taylor, F.; Gebhardt, B.; Tomaszewski, M.; Ellison, J.S.; Martin, G.V.; Levin, L.; Al-Shaikh, E.; Nicolas, J.; Bernstein, J.A. Allergy and immunotherapy: Are they related to migraine headache? Headache 2011, 51, 8–20. [Google Scholar] [CrossRef]
- Buse, D.; Manack, A.; Serrano, D.; Turkel, C.; Lipton, R. Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers. J. Neurol. Neurosurg. Psychiatry 2010, 81, 428–432. [Google Scholar] [CrossRef]
- Wang, S.J.; Fuh, J.L.; Young, Y.H.; Lu, S.R.; Shia, B.C. Prevalence of migraine in Taipei, Taiwan: A population-based survey. Cephalalgia 2000, 20, 566–572. [Google Scholar] [CrossRef]
- National Health Insurance Research Database. Available online: http://nhird.nhri.org.tw/en/index.html (accessed on 1 June 2020).
- Welge-Lüssen, A.; Hauser, R.; Probst, R. 3-year follow-up after endonasal microscopic paranasal sinus surgery in migraine and cluster headache. Laryngorhinootologie 1996, 75, 392–396. [Google Scholar] [CrossRef] [PubMed]
- Knight, Y.; Goadsby, P. The periaqueductal grey matter modulates trigeminovascular input: A role in migraine? Neuroscience 2001, 106, 793–800. [Google Scholar] [CrossRef]
- Katsarava, Z.; Lehnerdt, G.; Duda, B.; Ellrich, J.; Diener, H.; Kaube, H. Sensitization of trigeminal nociception specific for migraine but not pain of sinusitis. Neurology 2002, 59, 1450–1453. [Google Scholar] [CrossRef]
- Gryglas, A. Allergic rhinitis and chronic daily headaches: Is There a Link? Curr. Neurol. Neurosci. Rep. 2016, 16, 1–8. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Sabra, O.; Muhammad, A.M.; Al Zayer, M.; Altuwaijri, S. Frequency of migraine as a chief complaint in otolaryngology outpatient practice. Biomed. Res. Int. 2015, 2015, 173165. [Google Scholar] [CrossRef] [PubMed]
- Schreiber, C.P.; Hutchinson, S.; Webster, C.J.; Ames, M.; Richardson, M.S.; Powers, C. Prevalence of migraine in patients with a history of self-reported or physician-diagnosed sinus headache. Arch Intern. Med. 2004, 164, 1769–1772. [Google Scholar] [CrossRef] [Green Version]
- Eross, E.; Dodick, D.; Eross, M. The sinus, allergy and migraine study (SAMS). Headache 2007, 47, 213–224. [Google Scholar] [CrossRef]
- Goadsby, P.J.; Hoskin, K.L. The distribution of trigeminovascular afferents in the nonhuman primate brain Macaca nemestrina: Ac-fos immunocytochemical study. J. Anat. 1997, 190, 367–375. [Google Scholar] [CrossRef]
- Ciancarelli, I.; Tozzi-Ciancarelli, M.; Spacca, G.; Di Massimo, C.; Carolei, A. Relationship between biofeedback and oxidative stress in patients with chronic migraine. Cephalalgia 2007, 27, 1136–1141. [Google Scholar] [CrossRef]
- Ku, M.; Silverman, B.; Prifti, N.; Ying, W.; Persaud, Y.; Schneider, A. Prevalence of migraine headaches in patients with allergic rhinitis. Ann. Allergy Asthma Immunol. 2006, 97, 226–230. [Google Scholar] [CrossRef]
- Jayarathna, D.; Thenakoon, S.; Senananayaka, K.J. Migraine and neurological disorders comorbidity-consideration of sinus hypoxic nitric oxide theory for migraine. J. Neurol. Disord. 2014, 2, 1000175. [Google Scholar] [CrossRef]
- Bektas, H.; Karabulut, H.; Doganay, B.; Acar, B. Allergens might trigger migraine attacks. Acta Neurol. Belg. 2017, 117, 91–95. [Google Scholar] [CrossRef] [PubMed]
- Lateef, T.M.; Cui, L.; Nelson, K.B.; Nakamura, E.F.; Merikangas, K.R. Physical comorbidity of migraine and other headaches in US adolescents. J. Pediatr. 2012, 161, 308–313. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Patten, S.B. Long-term medical conditions and major depression in a Canadian population study at waves 1 and 2. J. Affect Disord. 2001, 63, 35–41. [Google Scholar] [CrossRef]
- Jung, A.C.; Staiger, T.; Sullivan, M. The efficacy of selective serotonin reuptake inhibitors for the management of chronic pain. J. Gen. Intern. Med. 1997, 12, 384–389. [Google Scholar] [CrossRef]
- Penn, I.W.; Chuang, E.; Chuang, T.Y.; Lin, C.L.; Kao, C.H. Bidirectional association between migraine and fibromyalgia: Retrospective cohort analyses of two populations. BMJ Open 2019, 9, e026581. [Google Scholar] [CrossRef] [Green Version]
- Martin, V.T.; Fanning, K.M.; Serrano, D.; Buse, D.C.; Reed, M.L.; Lipton, R.B. Asthma is a risk factor for new onset chronic migraine: Results from the American migraine prevalence and prevention study. Headache 2016, 56, 118–131. [Google Scholar] [CrossRef]
- Martinez, F.; Castillo, J.; Pardo, J.; Lema, M.; Noya, M. Catecholamine levels in plasma and CSF in migraine. J. Neurol. Neurosurg. Psychiatry. 1993, 56, 1119–1121. [Google Scholar] [CrossRef] [Green Version]
- Aupiais, C.; Wanin, S.; Romanello, S.; Spiri, D.; Moretti, R.; Boizeau, P.; Massano, D.; Zuccotti, G.V.; Crichiutti, G.; Kanagarajah, L. Association between migraine and atopic siseases in childhood: A potential protective role of anti-allergic drugs. Headache 2017, 57, 612–624. [Google Scholar] [CrossRef]
- Lau, C.I.; Lin, C.C.; Chen, W.H.; Wang, H.C.; Kao, C.H. Association between migraine and irritable bowel syndrome: A population-based retrospective cohort study. Eur. J. Neurol. 2014, 21, 1198–1204. [Google Scholar] [CrossRef]
Turbinate Submucosal Reduction Operation | Total | With | Without | p | |||
---|---|---|---|---|---|---|---|
Variables | n | % | n | % | n | % | |
118,275 | 95,016 | 80.33 | 23,259 | 19.67 | |||
Gender (Male) | 83,307 | 70.44 | 68,443 | 72.03 | 14,864 | 63.91 | <0.001 |
Age (years) | 37.58 ± 14.28 | 35.56 ± 12.78 | 45.85 ± 16.87 | <0.001 | |||
Age group (years) | <0.001 | ||||||
<30 | 44,678 | 37.77 | 39,810 | 41.90 | 4868 | 20.93 | |
30–45 | 40,317 | 34.09 | 33,320 | 35.07 | 6997 | 30.08 | |
≥45 | 33,280 | 28.14 | 21,886 | 23.03 | 11,394 | 48.99 | |
Diabetes mellitus | 2093 | 1.77 | 851 | 0.90 | 1242 | 5.34 | <0.001 |
Hypertension | 4348 | 3.68 | 2159 | 2.27 | 2189 | 9.41 | <0.001 |
Hyperlipidemia | 356 | 0.30 | 104 | 0.11 | 252 | 1.08 | <0.001 |
Depression | 404 | 0.34 | 103 | 0.11 | 301 | 1.29 | <0.001 |
Anxiety | 400 | 0.34 | 85 | 0.09 | 315 | 1.35 | <0.001 |
Chronic fatigue syndrome | 2 | 0.00 | 1 | 0.00 | 1 | 0.00 | 0.355 |
Fibromyalgia | 73 | 0.06 | 10 | 0.01 | 63 | 0.27 | <0.001 |
Irritable bowel syndrome | 27 | 0.02 | 8 | 0.01 | 19 | 0.08 | <0.001 |
Sleep disturbance | 6052 | 4.93 | 4457 | 4.48 | 1595 | 6.86 | <0.001 |
Temporomandibular joint disorder | 12 | 0.01 | 2 | 0.00 | 10 | 0.04 | <0.001 |
Dysmenorrhea | 4 | 0.00 | 1 | 0.00 | 3 | 0.01 | 0.026 |
Asthma | 1804 | 1.53 | 352 | 0.37 | 1452 | 6.24 | <0.001 |
Season | <0.001 | ||||||
Spring (March–May) | 31,062 | 26.26 | 24,846 | 26.15 | 6216 | 26.73 | |
Summer (June–August) | 30,437 | 25.73 | 24,789 | 26.09 | 5648 | 24.28 | |
Autumn (September–November) | 27,952 | 23.63 | 22,340 | 23.51 | 5612 | 24.13 | |
Winter (December–February) | 28,824 | 24.37 | 23,041 | 24.25 | 5783 | 24.86 | |
Location | <0.001 | ||||||
Northern Taiwan | 47,644 | 40.28 | 40,118 | 42.22 | 7526 | 32.36 | |
Middle Taiwan | 34,757 | 29.39 | 26,919 | 28.33 | 7838 | 33.70 | |
Southern Taiwan | 31,678 | 26.78 | 25,792 | 27.14 | 5886 | 25.31 | |
Eastern Taiwan | 4070 | 3.44 | 2095 | 2.20 | 1975 | 8.49 | |
Outlet islands | 126 | 0.11 | 92 | 0.10 | 34 | 0.15 | |
Urbanization level | <0.001 | ||||||
1 (Highest) | 44,393 | 37.53 | 37,016 | 38.96 | 7377 | 31.72 | |
2 | 57,057 | 48.24 | 46,318 | 48.75 | 10,739 | 46.17 | |
3 | 5222 | 4.42 | 3549 | 3.74 | 1673 | 7.19 | |
4 (Lowest) | 11,603 | 9.81 | 8133 | 8.56 | 3470 | 14.92 | |
Level of care | <0.001 | ||||||
Medical center | 55,660 | 47.06 | 47,288 | 49.77 | 8372 | 35.99 | |
Regional hospital | 51,281 | 43.36 | 38,961 | 41.00 | 12,320 | 52.97 | |
Local hospital | 11,334 | 9.58 | 8767 | 9.23 | 2567 | 11.04 | |
Insured premium (NT$) | <0.001 | ||||||
<18,000 | 115,477 | 97.63 | 92,717 | 97.58 | 22,760 | 97.85 | |
18,000–34,999 | 1748 | 1.48 | 1399 | 1.47 | 349 | 1.50 | |
35,000+ | 1050 | 0.89 | 900 | 0.95 | 150 | 0.64 |
Variables | Crude HR | 95% CI | 95% CI | p | Adjusted HR | 95% CI | 95% CI | p |
---|---|---|---|---|---|---|---|---|
Turbinate Submucosal Reduction Operation | ||||||||
0.759 | 0.569 | 0.911 | 0.011 * | 0.858 | 0.633 | 0.962 | 0.022 * | |
Gender | ||||||||
Male | 0.521 | 0.398 | 0.682 | <0.001 * | 0.603 | 0.458 | 0.794 | <0.001 * |
Female | Reference | Reference | ||||||
Age (years) | ||||||||
<30 | Reference | Reference | ||||||
30–45 | 1.569 | 1.018 | 2.501 | 0.041 * | 1.479 | 0.942 | 2.324 | 0.089 |
≥45 | 1.361 | 0.877 | 2.111 | 0.169 | 1.276 | 0.803 | 2.029 | 0.302 |
Diabetes mellitus | 0.531 | 0.289 | 0.975 | 0.041 * | 0.479 | 0.255 | 0.9 | 0.022 * |
Hypertension | 1.079 | 0.750 | 1.553 | 0.680 | 1.366 | 0.919 | 2.029 | 0.123 |
Hyperlipidemia | 1.148 | 0.566 | 2.329 | 0.701 | 1.028 | 0.493 | 2.143 | 0.941 |
Depression | 7.560 | 5.158 | 11.082 | <0.001 * | 4.348 | 2.826 | 6.69 | <0.001 * |
Anxiety | 6.398 | 4.418 | 10.894 | <0.001 * | 3.750 | 2.267 | 6.203 | <0.001 * |
Chronic fatigue syndrome | 10.813 | 1.515 | 77.160 | 0.018 * | 3.882 | 0.500 | 30.124 | 0.195 |
Fibromyalgia | 13.303 | 8.538 | 27.070 | <0.001 * | 7.326 | 3.427 | 15.661 | <0.001 * |
Irritable bowel syndrome | 6.849 | 1.682 | 27.881 | 0.007 * | 3.368 | 0.800 | 14.182 | 0.098 |
Sleep disturbance | 2.568 | 1.465 | 4.503 | 0.001 * | 1.711 | 0.954 | 3.067 | 0.071 |
Asthma | 2.226 | 1.270 | 3.901 | 0.005 * | 1.969 | 1.11 | 3.491 | 0.02 * |
Season | ||||||||
Spring (March–May) | Reference | Reference | ||||||
Summer (June–August) | 0.957 | 0.637 | 1.439 | 0.834 | 0.941 | 0.626 | 1.416 | 0.772 |
Autumn (September–November) | 1.097 | 0.748 | 1.609 | 0.636 | 1.042 | 0.709 | 1.532 | 0.832 |
Winter (December–February) | 1.225 | 0.822 | 1.825 | 0.319 | 1.198 | 0.801 | 1.787 | 0.381 |
Urbanization level | ||||||||
1 (Highest) | 0.765 | 0.494 | 1.185 | 0.231 | 0.970 | 0.603 | 1.560 | 0.900 |
2 | 1.139 | 0.776 | 1.674 | 0.507 | 1.409 | 0.941 | 2.111 | 0.096 |
3 | 0.940 | 0.525 | 1.683 | 0.835 | 1.037 | 0.578 | 1.863 | 0.902 |
4 (Lowest) | Reference | Reference | ||||||
Level of care | ||||||||
Medical center | 0.685 | 0.470 | 0.997 | 0.048 * | 0.672 | 0.445 | 1.015 | 0.059 |
Regional hospital | 0.873 | 0.621 | 1.228 | 0.438 | 0.825 | 0.583 | 1.168 | 0.278 |
Local hospital | Reference | Reference | ||||||
Insured premium (NT$) | ||||||||
<18,000 | Reference | Reference | ||||||
18,000–34,999 | 1.667 | 0.740 | 3.754 | 0.217 | 1.799 | 0.797 | 4.063 | 0.158 |
35,000+ | 0.691 | 0.097 | 4.927 | 0.712 | 0.695 | 0.125 | 6.399 | 0.912 |
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Cheng, C.-A.; Chang, Y.-H.; Cheng, C.-G.; Lin, H.-C.; Chung, C.-H.; Chien, W.-C. Turbinate Submucosal Reduction Operation Reduced Migraine Admission among Patients with Chronic Hypertrophic Rhinitis. Int. J. Environ. Res. Public Health 2020, 17, 5455. https://doi.org/10.3390/ijerph17155455
Cheng C-A, Chang Y-H, Cheng C-G, Lin H-C, Chung C-H, Chien W-C. Turbinate Submucosal Reduction Operation Reduced Migraine Admission among Patients with Chronic Hypertrophic Rhinitis. International Journal of Environmental Research and Public Health. 2020; 17(15):5455. https://doi.org/10.3390/ijerph17155455
Chicago/Turabian StyleCheng, Chun-An, Yin-Han Chang, Chun-Gu Cheng, Hung-Che Lin, Chi-Hsiang Chung, and Wu-Chien Chien. 2020. "Turbinate Submucosal Reduction Operation Reduced Migraine Admission among Patients with Chronic Hypertrophic Rhinitis" International Journal of Environmental Research and Public Health 17, no. 15: 5455. https://doi.org/10.3390/ijerph17155455